Competition Law and Patents : A Follow-on Innovation Perspective in the Biopharmaceutical Industry.

Preface
Acknowledgements
Cases
Part I The problem - access as a necessary element of follow-on innovation?
1. Biopharmaceutical R&D: the increased importance of cumulative innovation and related concerns
Part II The patent balance and working solutions in the patent system
2. The patent system as a system of balancing
3. The patent system and some potential safety nets
4. The right to health as an interpretive principle of patent law
PART III Antitrust as a complement to the patent system
5. Unilateral conduct, intellectual property rights and competition law: a systems' interaction
6. The duty to deal under Art. 82 EC
PART IV A more innovation sensitive approach to the interface of competition law and patents?
7. The duty to deal as applied to address technology access problems in the biopharmaceutical industry
Bibliography
Index.